Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
Almudena Aguilera-Diaz, Iria Vázquez, Beñat Ariceta, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0227986-e0227986
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms
Nikhil Sahajpal, Ashis K. Mondal, Tatiana Tvrdik, et al.
Journal of Molecular Diagnostics (2022) Vol. 24, Iss. 12, pp. 1279-1291
Open Access | Times Cited: 42
An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
Ala Almanaseer, Benjamin Chin‐Yee, Jenny Ho, et al.
Advances in Hematology (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 8
Significance of NPM1 Gene Mutations in AML
Andrew Hindley, Mark Catherwood, Mary Frances McMullin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10040-10040
Open Access | Times Cited: 37
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma
Catarina Maia, Noemí Puig, María‐Teresa Cedena, et al.
Blood (2020) Vol. 135, Iss. 26, pp. 2375-2387
Open Access | Times Cited: 33
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Laura Palomo, Mariam Ibáñez, María Abáigar, et al.
British Journal of Haematology (2019) Vol. 188, Iss. 5, pp. 605-622
Open Access | Times Cited: 35
Precision medicine and artificial intelligence: overview and relevance to reproductive medicine
Iman Hajirasouliha, Olivier Elemento
Fertility and Sterility (2020) Vol. 114, Iss. 5, pp. 908-913
Open Access | Times Cited: 30
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes
Nerea Berastegui, Marina Ainciburu, Juan P. Romero, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome
Francesca Guijarro, Mònica López‐Guerra, Jordi Morata, et al.
Blood Advances (2023) Vol. 7, Iss. 19, pp. 5799-5811
Open Access | Times Cited: 9
Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers
Nikhil Sahajpal, Ashis K. Mondal, Harmanpreet Singh, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3214-3214
Open Access | Times Cited: 8
Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms
Nikhil Sahajpal, Ashis K. Mondal, Sudha Ananth, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240976-e0240976
Open Access | Times Cited: 16
The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms
Tanja Belčič Mikič, Tadej Pajič, Samo Zver, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3371-3371
Open Access | Times Cited: 13
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
Yuan Ji, Rong He, Hassan B. Alkhateeb
Current Hematologic Malignancy Reports (2023) Vol. 18, Iss. 5, pp. 121-129
Open Access | Times Cited: 5
Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms
Paula Aguirre‐Ruiz, Beñat Ariceta, María C. Viguria, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3818-3818
Open Access | Times Cited: 12
Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era
Jong‐Mi Lee, Howon Lee, Ki‐Seong Eom, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 5, pp. 1033-1033
Open Access | Times Cited: 11
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis
Mirko Farina, Simona Bernardi, Nicola Polverelli, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2764-2764
Open Access | Times Cited: 11
The role of next-generation sequencing in acute myeloid leukemia
Marta Llop, Claudia Sargas, Eva Barragán
Current Opinion in Oncology (2022)
Closed Access | Times Cited: 8
Real-life use of ropeg-interferon α2b in polycythemia vera: patient selection and clinical outcomes
Francesca Palandri, Filippo Branzanti, Miro Venturi, et al.
Annals of Hematology (2024) Vol. 103, Iss. 7, pp. 2347-2354
Open Access | Times Cited: 1
Acute Myeloid Leukemia and Next-Generation Sequencing Panels for Diagnosis: A Comprehensive Review
Spandan Chaudhary, Pooja Chaudhary, Firoz Ahmad, et al.
Journal of Pediatric Hematology/Oncology (2024) Vol. 46, Iss. 3, pp. 125-137
Open Access | Times Cited: 1
The potential of proliferative and apoptotic parameters in clinical flow cytometry of myeloid malignancies
Stefan G.C. Mestrum, Anton H. N. Hopman, Frans C. S. Ramaekers, et al.
Blood Advances (2021) Vol. 5, Iss. 7, pp. 2040-2052
Open Access | Times Cited: 9
Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer
Martina Dameri, Lorenzo Ferrando, Gabriella Cirmena, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7154-7154
Open Access | Times Cited: 9
Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative Disorders
Audrey N. Jajosky, Nathaniel P Havens, Navid Sadri, et al.
American Journal of Clinical Pathology (2020) Vol. 156, Iss. 3, pp. 433-444
Closed Access | Times Cited: 7
Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms
Sun Hee Rosenthal, Анна Герасимова, Marie‐Aline Charles, et al.
PLoS ONE (2021) Vol. 16, Iss. 4, pp. e0243683-e0243683
Open Access | Times Cited: 7
Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome
Charlotte FM Hughes, Paolo Gallipoli, Rishu Agarwal
Pathology (2021) Vol. 53, Iss. 3, pp. 328-338
Open Access | Times Cited: 6
Optical Genome Mapping: Clinical Validation and Diagnostic Utility for Enhanced Cytogenomic Analysis of Hematological Neoplasms
Nikhil Sahajpal, Ashis K. Mondal, Tatiana Tvrdik, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia
Naranie Shanmuganathan, Carol Wadham, Daniel Thomson, et al.
Journal of Molecular Diagnostics (2022) Vol. 24, Iss. 7, pp. 803-822
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top